Skip to content
Screener

LiveRamp Holdings, Inc. RAMP Reportable Segment — Total other income, net

Similar metrics at other companies

Vaxcyte, Inc. logo
PCVXReportable Segment — Total other income, net
$25.23M-37.0%
Crinetics Pharmaceuticals logo
CRNXReportable Segment — Total other income, net
$12.53M-14.3%
Travere Therapeutics, Inc. logo
TVTXReportable Segment — Total other income, net
$193K-87.0%
Prime Medicine logo
PRMEReportable Segment — Total other income, net
$1.18M+49.6%
Enphase Energy logo
ENPHReportable Segment — Total other income, net
$10.38M+99.7%
Bicara Therapeutics logo
BCAXReportable Segment — Total other income
$4.08M-18.6%

Other financials

Income statement

See full
Revenue$214.0M+9.8%
Gross profit$150.9M+10.6%
Operating income$20.2M+179%
Net income$17.5M+126%
EPS (diluted)$0.28+133%

Balance sheet

See full
Cash & equivalents$363.5M0.0%
Total debt$33.1M-5.7%
Total equity$977.4M+3.1%
Total assets$1.3B+3.8%

Cash flow

See full
Operating cash flow$17.0M+208%
CapEx$703.0K+109%
Free cash flow$16.3M+201%

Valuation

See full
Market cap$2.3B+35.8%
Enterprise value$1.97B+44.3%
P/E14.8×-103×
P/S2.8×+0.5×

Profitability

See full
Gross margin70.8%-0.1pp
Operating margin11.6%
Net margin18.7%+16.8pp
FCF margin23.9%+4.8pp

Returns & leverage

See full
Return on equity16.2%+14.7pp
Debt / equity0.0×
Current ratio2.7×-0.2×

Where this comes from

Reported directly by LiveRamp Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The source filing: LiveRamp Holdings, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:16 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000733269-26-000047
Line itemFor the three months ended / June 30, 2026For the three months ended / June 30, 2025
Interest expense$(22)
Interest income3,0944,083
Other non-operating losses(3)(352)
Total other income, net$3,091$3,709

Item 1. [Financial Statements](#i614bfa0437c94dab800c0903e6f77240_211) [7](#i614bfa0437c94dab800c0903e6f77240_211)

FAQ

What is LiveRamp Holdings, Inc.'s reportable segment — total other income, net?
LiveRamp Holdings, Inc. (RAMP) reported reportable segment — total other income, net of $3.09M in Q2 2026.
How has LiveRamp Holdings, Inc.'s reportable segment — total other income, net changed year-over-year?
LiveRamp Holdings, Inc.'s reportable segment — total other income, net decreased by 16.7% year-over-year, from $3.71M to $3.09M.
What is the long-term trend for LiveRamp Holdings, Inc.'s reportable segment — total other income, net?
Over 3 years (2023 to 2026), LiveRamp Holdings, Inc.'s reportable segment — total other income, net has grown at a 28.1% compound annual growth rate (CAGR), from $6.95M to $14.6M.
What does reportable segment — total other income, net mean?
This metric represents the aggregate net result of all non-operating income and expense items attributable to the reportable segment. It provides a comprehensive view of the segment's peripheral financial activities, including interest income, interest expense, and other miscellaneous gains or losses. It is essential for reconciling the segment's operating income with its total contribution to the company's bottom line.

Ask your AI about LiveRamp Holdings, Inc.'s reportable segment — total other income, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude